Updated February 2024
Read a full explanation of the development process of a Green-top Guideline.
Please note that all expected publication dates are estimates and are subject to change based on a number of factors.
|
Title |
Stage of development |
Expected publication date |
|
(no. 31) Investigation and Care of a Small-for-Gestational-Age Fetus and a Growth Restricted Fetus |
Final draft stage (post-peer review) |
Q2 2024 |
|
(no. 55) Care of Late Intrauterine Fetal Death and Stillbirth |
Final draft stage (post-peer review) |
Q2 2024 |
|
(no. 64) Identification and management of maternal sepsis during and following pregnancy |
Final draft stage (post-peer review) |
Q2 2024 |
|
(no. 69) The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum |
Final draft stage (post-peer review) |
Q1 2024 |
|
(new) Care of Transgender and Gender Diverse Adults within Obstetrics and Gynaecology |
Final draft stage (post-peer review) |
Q3 2024 |
|
|
|
|
|
(no. 51) Management of Monochorionic Twin Pregnancy |
Post-Peer review stage |
Q3 2024 |
|
(New) Management of Thyroid Disorders in Pregnancy |
Post-Peer review stage |
Q2 2024 |
|
(no. 57) Reduced Fetal Movement |
Post-Peer review stage |
Q2 2024 |
|
(no. 59) Best Practice in Outpatient Hysteroscopy (JOINT WITH BSGE) |
Post-Peer review stage |
Q2 2024 |
|
|
|
|
|
(no. 12) Pregnancy and Breast Cancer (JOINT WITH Association for Breast Surgery) |
Peer review stage |
Q4 2024 |
|
|
|
|
|
(no. 49) Laparoscopic entry and risk reduction techniques in gynaecological surgery |
Third draft stage |
Q4 2024 |
|
|
|
|
|
(no. 5) Management of Ovarian Hyperstimulation Syndrome |
Second draft stage |
Q4 2024 |
|
(no.42) Shoulder Dystocia |
Second draft stage |
Q1 2025 |
|
|
|
|
|
(new) Management of Vulval Intraepithelial Neoplasia |
First draft stage |
Q3 2025 |
|
(New) Non-Invasive Prenatal Testing |
First draft stage |
Q2 2025 |
|
(no. 29) Management of Third and Fourth degree tears following vaginal birth |
First draft stage |
Q3 2025 |
|
|
|
|
|
(no. 62) Ovarian Masses in Premenopausal Women, Management of Suspected (JOINT WITH BSGE) |
First draft stage |
Q4 2025 |
|
(no. 21) Diagnosis and Management of Ectopic Pregnancy |
First draft stage |
Q3 2025 |
|
(no 27a) Placenta Praevia and Placenta Accreta: Diagnosis and Management |
First draft stage |
Q4 2025 |
|
(no 41) Management of Chronic Pelvic Pain |
First draft stage |
Q4 2025 |
|
(no 68) Epilepsy in Pregnancy |
First draft stage |
Q4 2025 |
|
|
|
|
|
(no. 63) Antepartum Haemorrhage |
Scoping stage |
Q1 2026 |
|
(no. 72) Care of Women with Obesity in Pregnancy |
Scoping stage |
Q3 2026 |
|
(no. 36) Group B Streptococcal Disease |
Scoping stage |
Q3 2026 |
|
(no. 37a) Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk |
Scoping stage |
Q3 2026 |
|
(no. 37b) Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management |
Scoping stage |
Q3 2026 |
|
(new) Alternatives to HRT for Management of Symptoms of the Menopause |
Scoping stage |
Q3 2026 |